S-1: AtlasClear Holdings Files for Resale of Up to 37.9 Million Shares of Common Stock
S-1 Filing
AtlasClear Holdings has filed a registration statement for the potential resale of up to 37,885,852 shares of its common stock by selling stockholders.
Summary
- AtlasClear Holdings has filed a Form S-1 registration statement with the SEC to allow selling stockholders to offer and sell up to 37,885,852 shares of the company's common stock.
- These shares consist of merger consideration shares, shares issuable to sellers of Wilson-Davis, shares issuable to Pacsquare Technologies, shares issued to Commercial Bancorp, shares issuable to Funicular Funds, shares issued to Qvent LLC, shares issued to Calabrese Consulting LLC, shares issued to Grant Thornton LLP, shares issued to IB Capital LLC, shares issued to Outside The Box Capital Inc., shares issuable to Carriage House Capital, Inc., shares issuable to Interest Solutions, LLC, shares issuable to JonesTrading Institutional Services LLC, shares issuable to Winston & Strawn LLP, shares issuable to Lead Nector and shares issuable to Tau.
- The company will not receive any proceeds from the sale of these shares by the selling stockholders.
- As of April 30, 2024, the number of shares of Common Stock that may be offered for resale by the Selling Stockholders pursuant to this prospectus is almost 3.1 times larger than the number of outstanding shares of Common Stock.
- The company will bear all costs, expenses and fees in connection with the registration of the resale of the Offered Shares.
- The Selling Stockholders will bear all commissions and discounts, if any, attributable to their respective sales of the Offered Shares.
- The shares of Common Stock are listed on the New York American LLC (the NYSE) under the symbol ATCH.
- On May 10, 2024, the last sale price of the Common Stock as reported on the NYSE was $0.83 per share.
Sentiment
Score: 4
Explanation: The document is primarily factual, but the large number of shares being registered for resale and the potential for dilution raise concerns, resulting in a neutral to slightly negative sentiment.
Negatives
- Sales of a substantial number of shares of Common Stock in the public markets, including by the Selling Stockholders, some of whom obtained their shares at prices or values below the current market price, or the perception in the market that such sales could occur, could result in a significant decline in the public trading price of the Common Stock.
- The resale, or expected or potential resale, of a substantial number of shares of our Common Stock in the public market could adversely affect the market price for our Common Stock and make it more difficult for our stockholders to sell their shares of Common Stock at times and prices that they feel are appropriate.
Risks
- Future sales, or the perception of future sales, by the Company or its stockholders in the public market could cause the market price for the Common Stock to decline.
- An active market for our securities may not develop, which would adversely affect the liquidity and price of our securities.
- Issuances of shares of Common Stock pursuant to the Pacsquare Purchase Agreement, or to settle accrued expenses and obligations, and conversion of any amounts under the Seller Notes, Funicular Note and the Chardan Note, each as defined herein, would result in substantial dilution of our stockholders and may have a negative impact on the market price of our Common Stock.
Future Outlook
The company aims to build a cutting-edge technology-enabled financial services firm and expects to power innovation in fintech, investing, and trading.
Industry Context
The announcement reflects a trend of fintech companies seeking to provide comprehensive solutions to financial services firms, particularly those underserved by larger institutions.
Related Party Transactions
- Atlas FinTech will also receive up to $20 million of shares of Common Stock (Software Products Earn Out Shares), which will be issued to Atlas FinTech upon certain milestones based on the achievement of certain revenue targets of software products contributed to AtlasClear by Atlas FinTech and Atlas Financial Technologies Corp. following the Closing.
Stakeholder Impact
- Existing shareholders may experience dilution due to the potential sale of a large number of shares.
- The market price of the Common Stock could be negatively impacted by the potential sale of a large number of shares.
Next Steps
- The selling stockholders may offer and sell the securities covered by this prospectus in a number of different ways and at varying prices.
- The Company agreed (i) to file, within 30 days of the Closing Date, a registration statement with the SEC, registering the resale of the shares of Common Stock issuable upon conversion of the Notes and (ii) if necessary to allow any of the Notes to be converted into shares of Common Stock in accordance with the rules of the NYSE, to seek stockholder approval for the issuance of such shares, including by filing a proxy statement by no later than April 30, 2024.
Key Dates
| Date | Description |
|---|---|
| April 15, 2022 | Date of the Stock Purchase Agreement by and among Wilson-Davis & Co., Inc., all of its stockholders (the Wilson-Davis Sellers) and AtlasClear, Inc. |
| September 13, 2023 | Date of the Marketing Services Agreement, between OTB and Quantum |
| February 9, 2024 | Date of the Securities Purchase Agreement, between AtlasClear Holdings and Quantum |
| February 9, 2024 | Date of the Satisfaction and Discharge Agreement, between Grant Thornton and the Company |
| February 9, 2024 | Date of the Satisfaction and Discharge Agreement, between IB and the Company |
| February 9, 2024 | Date of the Satisfaction and Discharge Agreement, between Calabrese and the Company |
| February 16, 2024 | Date of the Source Code Purchase Agreement and Master Services Agreement, between Pacsquare and AtlasClear |
| February 19, 2024 | Date of the Consulting Agreement, between Carriage and the Company |
| February 26, 2024 | Date of the Amendment to the Agreement and Plan of Merger, between AtlasClear and Commercial Bancorp |
| April 4, 2024 | Date of the Satisfaction and Discharge Agreement, between Calabrese and the Company |
| April 29, 2024 | Date of the non-binding term sheet entered into between the Company and Tau |
| April 30, 2024 | As of April 30, 2024, the number of shares of Common Stock that may be offered for resale by the Selling Stockholders pursuant to this prospectus is almost 3.1 times larger than the number of outstanding shares of Common Stock. |
| May 10, 2024 | On May 10, 2024, the last sale price of the Common Stock as reported on the NYSE was $0.83 per share. |
| May 13, 2024 | Date of this prospectus |
| June 30, 2024 | Accrued interest on the Interest Solutions Note is payable monthly, beginning on June 30, 2024, at a rate of 13% per annum. |
| June 30, 2024 | Accrued interest on the JonesTrading Note is payable monthly, beginning on June 30, 2024, at a rate of 13% per annum. |
| August 9, 2024 | Pursuant to the Winston Agreement, the Company may issue $2,500,000 worth of shares of Common Stock as payment for legal services, in three equal installments of $833,333 beginning on August 9, 2024. |
Keywords
common stock, resale, selling stockholders, registration statement, shares, atch, atlasclear holdings, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.